A phase 1/2 of a combination of cetuximab and taxane for "triple negative" breast cancer patients. (Q54352127)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase 1/2 of a combination of cetuximab and taxane for "triple negative" breast cancer patients. |
scientific article |
Statements
A phase 1/2 of a combination of cetuximab and taxane for "triple negative" breast cancer patients. (English)
1 reference
Hovav Nechushtan
1 reference
Gilad Vainer
1 reference
Hana Stainberg
1 reference
Asher Y Salmon
1 reference
Tamar Hamburger
1 reference
Tamar Peretz
1 reference
14 May 2014
1 reference
1 reference
23
1 reference
435-438
1 reference
4
1 reference
Identifiers
1 reference